INVO
$0.20
Invo Bioscience
$.01
4.25%
INVO
Earnings Whisper ®
N/A
2nd Quarter June 2023
Consensus:  $0.00
Revenue:  N/A
Monday
Aug 14
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Monday, May 15, 2023

What do you expect when INVO reports earnings?
Beat
Meet
Miss

Where is INVO's stock price going from here?
Up
Flat
Down
Stock chart of INVO
Analysts
Summary of analysts' recommendations for INVO
Score
Grade
Pivots
Resistance
$0.26
$0.24
$0.22

$0.20

Support
$0.18
$0.16
$0.14
Tweet
Growth
Description
INVO Bioscience is a medical device company, headquartered in Beverly, Massachusetts, focused on creating simplified, lower cost treatment options for patients diagnosed with infertility. It engages in the development and manufacture of its lead product, INVOcell, a novel medical device used in infertility treatment that enables egg fertilization and early embryo development in the woman's vaginal cavity. The company was founded by Claude Ranoux, MD, a noted expert in the field of reproductive health, infertility and embryology. INVO Bioscience focuses on selling its product to IVF centers and physicians through distributors, as well as directly to physicians in Europe, Canada, Latin America, and the Middle East.